ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,631, issued on May 12, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"Systems and methods for quantifying retrograde trans-synaptic degeneration" was invented by Omar Al-Louzi (Los Angeles) and Pascal Sati (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for quantifying retrograde trans-synaptic degeneration (rTSD) in a patient includes receiving optical coherence tomography (OCT) image data associated with a left retina and a right retina of the patient. The method further includes analyzing the OCT image data to determine a thickness of one or more retinal layers of the left retina and one or more retinal layers of ...